Integra LifeSciences Holdings Cash Flow Reinvestment Rate
Integra LifeSciences Holdings cash flow reinvestment rate. Integra LifeSciences Holdings (IART) has a Cash Flow Reinvestment Rate of 1.51x as of March 2026, reinvesting $14.85 Million (capex $14.85 Million ) from operating cash flow of $9.80 Million. See IART FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Integra LifeSciences Holdings (1999–2025)
Cash flow reinvestment rate of Integra LifeSciences Holdings from 1999 to 2025. Historical reinvestment intensity for Integra LifeSciences Holdings across 26 annual periods. Explore Integra LifeSciences Holdings (IART) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Integra LifeSciences Holdings Cash Flow Reinvestment Rate by Year (1999–2025)
Integra LifeSciences Holdings cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Integra LifeSciences Holdings. For the full cash flow conversion analysis, see cash flow conversion of Integra LifeSciences Holdings.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.86x | $93.86 Million | $50.38 Million | $81.44 Million | ▼ -51.3% |
| 2024 | 3.83x | $495.23 Million | $129.38 Million | $104.42 Million | ▲ +232.6% |
| 2023 | 1.15x | $161.04 Million | $139.96 Million | $66.86 Million | ▲ +485.3% |
| 2022 | 0.20x | $51.99 Million | $264.47 Million | $47.09 Million | ▲ +27.5% |
| 2021 | 0.15x | $48.16 Million | $312.43 Million | $48.08 Million | ▼ -56.2% |
| 2020 | 0.35x | $71.73 Million | $203.83 Million | $63.89 Million | ▼ -40.5% |
| 2019 | 0.59x | $136.87 Million | $231.43 Million | $134.53 Million | ▲ +50.1% |
| 2018 | 0.39x | $78.65 Million | $199.68 Million | $77.74 Million | ▼ -26.0% |
| 2017 | 0.53x | $60.94 Million | $114.54 Million | $43.50 Million | ▼ -31.2% |
| 2016 | 0.77x | $89.95 Million | $116.41 Million | $47.33 Million | ▲ +45.0% |
| 2015 | 0.53x | $50.36 Million | $94.48 Million | $33.41 Million | ▼ -28.6% |
| 2014 | 0.75x | $59.35 Million | $79.46 Million | $42.40 Million | ▼ -16.9% |
| 2013 | 0.90x | $47.85 Million | $53.27 Million | $47.85 Million | ▼ -26.7% |
| 2012 | 1.23x | $72.00 Million | $58.72 Million | $69.03 Million | ▲ +232.9% |
| 2011 | 0.37x | $38.42 Million | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $37.14 Million | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $27.57 Million | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $13.40 Million | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $22.57 Million | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $11.52 Million | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $8.05 Million | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $8.51 Million | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $3.84 Million | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $2.25 Million | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $2.86 Million | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $17.30 Million | $2.50 Million | $17.30 Million | — |